pembrolizumab,cisplatin,gemcitabine
merck
['keytruda', 'key,note,966', 'merck']
merck presents p-iii trial (keynote-966) results of keytruda for advanced or unresectable biliary tract cancer at aacr 2023 published in the lancet 
Real-time summarized News in 3 shots from pharma, biotech, medtech, digital health and life sciences industry readable in 60 seconds